Potential treatment for drug-resistant H7N9 influenza virus comes closer to reality
A new research is showing promise in helping to fight novel drug-resistant H7N9 influenza virus, which has caused more than 130 human infections with 43 deaths in China.
The study by Juergen Richt from Kansas State University is working with scientists at Hemispherx Biopharma Inc. to develop novel pharmacological treatments.